Hi, my name is Dylan Archer and I have type 1 diabetes, and I LOVE to race! Type 1 is NOT stopping me! When I was 5 years old, way back in 2013, Dad picked me up from school, and (as usual) we started talking about racing. Dad started racing when he was 16, and we often talked about how much fun it was. Well, this conversation ended a bit differently because Dad asked if I was ready! I got my first go-kart that summer, and in no time, I was hooked! It was a little scary at first, but once I started to go fast I sure had fun! For the first couple of years of racing, I was reaching for the stars ..read more

By: Sarah Hathaway On October 10th, 2022 I earned my Life rank in Scouts BSA and began focusing on what was once a faraway goal: Eagle Scout. I had some ideas for my project and I knew I wanted to do something that means a lot to me and benefits as many people as possible; this led me to think about the Children’s Diabetes Foundation. I am an advocate for the organization and I know CDF has made an impact on others just like me so I was hoping I could come up with a plan to help families affected by T1D. I reached out to the Community Engagement Manager, Sydney. I believe that she was really ..read more

My name is Gracie Lambrecht and I have been living with type 1 diabetes for 12 of the 16 years of my life. Even though I lived for a few years T1D-less, I can’t remember a life without it and while I wish I could say it’s been a walk in the park to deal with, it most definitely has not. As a kid, the burden of pricking fingers, changing pump sites, and treating low blood sugars at midnight was not something that I was really tasked with handling. My parents took the responsibility of my diabetes care so I could be as “normal” of a kid as I could be. As I got older, I began taking more respons ..read more

                    Type 1 diabetes expected to surge among U.S. teens The post Type 1 diabetes expected to surge among U.S. teens appeared first on Children's Diabetes Foundation ..read more

                          New insulin pump system helps manage type 1 diabetes easier with less effort The post New insulin pump system helps manage type 1 diabetes easier with less effort appeared first on Children's Diabetes Foundation ..read more

Type 1 diabetes mellitus (T1DM) is characterized by a gradual loss of functional β-cells, leading to reliance on insulin and increased risk of complications resulting from hypoglycaemia and hyperglycaemia. Preserving β-cell function, particularly in patients newly diagnosed with T1DM, has been a focus of research for many years, but success has been limited. Furthermore, in the 1980s a theory was put forward that high glucose levels exacerbated the decline in β-cells (termed the glucotoxicity theory). In a single trial design, two papers have examined two potential approaches for preserving ..read more

In 2023, Dr. Paul Wadwa has authored the first paper in NEJM on Control-IQ in young children and Dr. Greg Forlenza has authored the first paper in JAMA on use of Verapamil to prolong islet survival in new onset diabetes. The BDC team conducted the FDA approval studies for the Medtronic 780G, Tandem Control-IQ, Insulet OP5, and Beta Bionics iLet. We anticipate that by the end of the year there will be four excellent automated insulin delivery systems on the market in the United States and all were developed and studied as part of the work of our team at BDC. Verapamil is a calcium channel bloc ..read more

New Therapy First to Target Type 1 Diabetes Disease Process A Barbara Davis Center for Diabetes patient became the first person in Colorado to receive a newly approved drug aimed at delaying onset of clinical stage type 1 diabetes. Erik Aeling was the first person in Colorado to receive the newly approved drug. The Aelings also know what a blessing it could be for them and families like theirs to delay the start of type 1 for Erik; in turn delaying the financial strain of diabetes, the number of years Erik will live with this daily challenge, and the possible complications type 1 comes with ..read more

Eli Lilly has a ripple effect on making insulin more cost effective for T1Ds. Every day patients make critical decisions in rationing their insulin and we are hopeful this will help stop families from having to make such sacrifices. Thank you to Eli Lilly, Novo Nordisk, Sanofi! Watch the interview with Dr. Satish Garg: Diabetes doctor says it’s “high time” insulin prices are lowered Read more here: Novo Nordisk will cut some U.S. insulin prices by up to 75% starting next year Sanofi becomes latest drugmaker to announce insulin price cuts, capping cost at $35 for the privately insure ..read more

Congratulations Dr. Satish Garg for being named the winner of the ATTD Lilly 2023 Insulin Centennial Award. This prestigious award is given to doctors who have made significant contributions to diabetes treatment. Dr. Garg has been an international leader for insulin therapy in both type 1 and type 2 diabetes, with expertise in clinical trials and methods of insulin delivery. Dr. Garg joined the BDC in 1988 and founded the adult clinic as senior faculty in 1992. He has also served as the director of the ATDC Keystone Diabetes conference since 2005 The post Dr. Satish Garg to Win TTD Lill ..read more